SIBICORT

This brand name is authorized in Estonia, Finland

Active ingredients

The drug SIBICORT contains a combination of these active pharmaceutical ingredients (APIs):

1 Chlorhexidine
UNII MOR84MUD8E - CHLORHEXIDINE GLUCONATE

Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high.

Read about Chlorhexidine
2 Hydrocortisone
UNII WI4X0X7BPJ - HYDROCORTISONE

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Read about Hydrocortisone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D07BA04 Hydrocortisone and antiseptics D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BA Corticosteroids, weak, combinations with antiseptics
Discover more medicines within D07BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1035403
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 024604, 025734, 195339

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈